Oncodesign Precision Medicine Société anonyme (EPA:ALOPM)
0.3300
-0.0130 (-3.79%)
Last updated: Jul 13, 2026, 5:30 PM CET
EPA:ALOPM Revenue
In the year 2025, Oncodesign Precision Medicine Société anonyme had annual revenue of 1.81M EUR with 10.87% growth. Oncodesign Precision Medicine Société anonyme had revenue of 1.07M in the half year ending December 31, 2025, with 57.63% growth.
Revenue
1.81M
Revenue Growth
+10.87%
P/S Ratio
3.47
Revenue / Employee
139.45K
Employees
13
Market Cap
6.28M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.81M | 177.80K | 10.87% |
| Dec 31, 2024 | 1.64M | -104.72K | -6.02% |
| Dec 31, 2023 | 1.74M | -6.55M | -79.02% |
| Dec 31, 2022 | 8.29M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition